Effectiveness of doubling the daily dose of Proton pump inhibitors in Preventing Stress Ulcer Bleeding in Perioperative Patients with Risk Factors: A Propensity Score - Matched Cohort Study
Abstract
Objective: : Non-critically ill perioperative patients exhibit lower gastrointestinal bleeding risks with more controllable risk factors than critically ill patients. However, the specific preventive medication design of proton pump inhibitors (PPIs) still requires more support. The aim of this study is to investigate whether mild patients with risk factors for concomitant medication can improve the prevention of gastrointestinal bleeding by increasing the frequency of administration.
Methods:: This study is a single-center, retrospective study through propensity score - matched cohort. From August 2022 to December 2023, we screened 1,057 patients using lansoprazole for injection with risk factors for developing stress ulcers. The postoperative changes in hemoglobin levels were employed to evaluate the severity of gastrointestinal hemorrhage following the exclusion of other potential etiologies contributing to bleeding.
Results:: Overall, dose escalation demonstrated a marginal association with reduced postoperative ulcer-related gastrointestinal bleeding (odds ratio [OR] 1.385; 95% confidence interval [CI], 0.76–2.52; p < 0.05). In subgroup analyses, younger patients (<65 years) (OR 2.463; 95% CI, 1.128–5.378; p < 0.05), and those without anticoagulant/antiplatelet therapy (AA) (OR 1.813; 95% CI, 0.796–4.128; p < 0.05) showed a potential and enhanced therapeutic response.
Conclusions:: The dosing frequency of PPIs may improve the prophylactic efficacy against…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 1,057 participants or records.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.